Anti-Human BLys Recombinant Antibody (Belimumab) (CAT#: TAB-030)

Recombinant monoclonal antibody to Human BLyS. Belimumab (trade name Benlysta, previously known as LymphoStat-B) is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). B cells are responsible for part of the normal immune response, and also for the over-aggressive immune response in autoimmune diseases like systemic lupus erythematosus (SLE).


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Tested Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
SDS-PAGE

Figure 1 Anti-Human BLys Recombinant Antibody (TAB-030) in SDS-PAGE

Figure 1 Anti-Human BLys Recombinant Antibody (TAB-030) in SDS-PAGE

SDS-PAGE analysis of TAB-030 in non-reduced (Lane 1) and reduced (Lane 2) conditions.

SEC-HPLC

Figure 2 Anti-Human BLys Recombinant Antibody (TAB-030) in HPLC

Figure 2 Anti-Human BLys Recombinant Antibody (TAB-030) in HPLC

HPLC analysis of TAB-030 shows the purity is>95%.


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG1 - lambda
  • Specificity
  • Tested positive against native human antigen
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, ICC and most other immunological methods.
  • Trade name
  • Benlysta
  • CAS
  • 356547-88-1
  • Generic Name
  • Belimumab
  • ATC Code
  • L04AA26
  • UNII
  • 73B0K5S26A
  • MW
  • 151.8 kDa
  • Related Disease
  • Systemic lupus erythematosus (SLE)

Product Property

  • Purity
  • Purity >95% by SDS-PAGE.
  • Storage
  • At -20°C for one year.

Target

  • Alternative Names
  • Belimumab;Benlysta;356547-88-1;HGS1006;Benlysta;LymphoStat-B;B-lymphocyte stimulator (BLyS);TNFSF13B;tumor necrosis factor (ligand) superfamily, member 13b;TNFSF20;tumor necrosis factor ligand superfamily member 13B;BAFF;BLYS;CD257;TALL 1;TALL1;THANK;delt

Related Resources

  • Biosimilar Overview
Please refer to Belimumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Belimumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Belimumab"

Afuco™ Anti-TNFSF13B ADCC Recombinant Antibody (Belimumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Human BLyS. Belimumab (trade name Benlysta, previously known as LymphoStat-B) is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). B cells are responsible for part of the normal immune response, and also for the over-aggressive immune response in autoimmune diseases like systemic lupus erythematosus (SLE).

See other products for "TNFSF13B"

Neutralizing Antibody

CAT Product Name Application Type
NEUT-2184CQ Rat Anti-TNFSF13B Recombinant Antibody (clone 8F10) Neut, FC, IHC, IHC-Fr Rat IgG2a
NEUT-2185CQ Mouse Anti-TNFSF13B Recombinant Antibody (clone CBL701) Neut Mouse IgG2b

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-030 Afuco™ Anti-TNFSF13B ADCC Recombinant Antibody (Belimumab), ADCC Enhanced FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody
AFC-TAB-216 Afuco™ Anti-TNFSF13B ADCC Recombinant Antibody (Tabalumab), ADCC Enhanced FuncS, IF, Neut, ELISA, FC, IP ADCC enhanced antibody

Submit a review or a question
There are currently no Customer reviews or questions for TAB-030. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare